Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. That said, here is one profitable company that balances growth and profitability and two best left off your watchlist.
Two Stocks to Sell:
Artivion (AORT)
Trailing 12-Month GAAP Operating Margin: 7.6%
Formerly known as CryoLife until its 2022 rebranding, Artivion (NYSE: AORT) develops and manufactures medical devices and preserves human tissues used in cardiac and vascular surgical procedures for patients with aortic disease.
Why Are We Hesitant About AORT?
- Smaller revenue base of $441.3 million means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
- Ability to fund investments or reward shareholders with increased buybacks or dividends is restricted by its weak free cash flow margin of -0.6% for the last five years
- Low returns on capital reflect management’s struggle to allocate funds effectively
At $35.43 per share, Artivion trades at 43.6x forward P/E. Check out our free in-depth research report to learn more about why AORT doesn’t pass our bar.
DHT Holdings (DHT)
Trailing 12-Month GAAP Operating Margin: 60.8%
With each vessel capable of carrying roughly 2 million barrels of oil—enough to fill about 125 Olympic swimming pools—DHT Holdings (NYSE: DHT) operates very large crude carriers that transport crude oil across international routes for energy companies and traders.
Why Does DHT Give Us Pause?
- Annual sales declines of 7.6% for the past five years show its products and services struggled to connect with the market during this cycle
- Modest revenue base of $370.3 million gives it less fixed cost leverage and fewer distribution channels than larger companies
- Gross margin of 30.9% reflects its high production costs and unfavorable asset base
DHT Holdings is trading at $17.93 per share, or 9.3x forward P/E. Dive into our free research report to see why there are better opportunities than DHT.
One Stock to Buy:
LSI (LYTS)
Trailing 12-Month GAAP Operating Margin: 6.7%
Enhancing commercial environments, LSI (NASDAQ: LYTS) provides lighting and display solutions for businesses and retailers.
Why Is LYTS a Good Business?
- Annual revenue growth of 16.1% over the last five years was superb and indicates its market share increased during this cycle
- Performance over the past five years shows its incremental sales were extremely profitable, as its annual earnings per share growth of 45% outpaced its revenue gains
- Free cash flow margin expanded by 7.2 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends
LSI’s stock price of $18.22 implies a valuation ratio of 14.3x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
